Decibel, Regeneron enter hearing loss collaboration

Decibel Therapeutics Inc. (Boston, Mass.) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) began a collaboration to discover and develop hearing loss and tinnitus therapies for up to seven years.

Decibel President and CEO Steven Holtzman told BioCentury both parties will commit 50% of "total resources" to the collaboration in the form of cash, research personnel and scientific capabilities...